De Fino, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 1.565
AS - Asia 1.202
EU - Europa 1.121
SA - Sud America 267
AF - Africa 37
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.200
Nazione #
US - Stati Uniti d'America 1.536
SG - Singapore 570
DE - Germania 373
CN - Cina 261
SE - Svezia 227
BR - Brasile 222
VN - Vietnam 113
IT - Italia 112
FR - Francia 107
GB - Regno Unito 67
IE - Irlanda 53
IN - India 49
UA - Ucraina 49
ID - Indonesia 43
BD - Bangladesh 35
FI - Finlandia 34
RU - Federazione Russa 29
IQ - Iraq 23
HK - Hong Kong 21
JP - Giappone 20
AR - Argentina 16
TR - Turchia 16
AT - Austria 11
PL - Polonia 10
CI - Costa d'Avorio 9
BE - Belgio 8
NL - Olanda 8
ZA - Sudafrica 8
CA - Canada 7
CL - Cile 7
JO - Giordania 7
CO - Colombia 6
EC - Ecuador 6
MA - Marocco 6
MX - Messico 6
ES - Italia 5
IL - Israele 5
IR - Iran 5
SA - Arabia Saudita 5
CH - Svizzera 4
KR - Corea 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
KE - Kenya 3
LT - Lituania 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GR - Grecia 2
JM - Giamaica 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
NA - Namibia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
Totale 4.200
Città #
Singapore 333
Chandler 313
San Jose 192
Ashburn 137
Beijing 67
Dublin 53
Los Angeles 43
Jakarta 38
New York 38
San Mateo 38
Wilmington 38
Hanoi 37
Jacksonville 36
Ho Chi Minh City 35
Lauterbourg 33
Nürnberg 31
Boston 27
Milan 26
Nanjing 23
Hong Kong 20
Dallas 19
Moscow 19
Munich 19
Princeton 19
São Paulo 19
Ann Arbor 18
Rome 16
Frankfurt am Main 15
Helsinki 15
Tokyo 15
Cattolica 14
Chicago 14
Nanchang 14
Dearborn 13
Norwalk 13
Buffalo 12
Hefei 12
Houston 12
Lawrence 12
Santa Clara 12
Atlanta 11
Shanghai 11
Marseille 10
Rio de Janeiro 10
Abidjan 9
Chennai 9
London 9
Baghdad 8
Bremen 8
Brooklyn 8
Brussels 8
Falls Church 8
Hebei 8
Nuremberg 8
Woodbridge 8
Amman 7
Tukwila 7
Dhaka 6
Johannesburg 6
Mountain View 6
Pune 6
The Dalles 6
Amsterdam 5
Düsseldorf 5
Fairfield 5
Haiphong 5
Izmir 5
Kent 5
Lviv 5
Ninh Bình 5
Orem 5
Portsmouth 5
Seattle 5
Tianjin 5
Vienna 5
Andover 4
Ankara 4
Caxias do Sul 4
Coquimbo 4
Council Bluffs 4
Denver 4
Fremont 4
Kunming 4
Leawood 4
Mumbai 4
Redwood City 4
Seoul 4
Stockholm 4
São Gonçalo 4
Tashkent 4
Tehran 4
Turku 4
Warsaw 4
Wroclaw 4
Auckland 3
Augusta 3
Belo Horizonte 3
Boardman 3
Brasília 3
Bắc Giang 3
Totale 2.196
Nome #
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 254
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 177
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 170
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 166
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 161
Idiopathic inflammatory myopathies evaluated by near infrared spectroscopy 158
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 149
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 148
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 146
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 142
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 126
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 125
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 124
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 119
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 118
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 116
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 115
A unique case of multiphasic ADEM or what else? 115
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis 113
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 112
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 110
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 108
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 107
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 106
Magnetic resonance imaging pattern recognition in sporadic Inclusion-Body Myositis 104
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 97
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 96
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 95
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture Analysis 94
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 94
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy 91
Delayed hypersensitivity to dimethyl fumarate: Report of 1 case and literature review 89
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 77
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis 76
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 68
Totale 4.266
Categoria #
all - tutte 18.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022321 30 6 4 42 12 13 0 50 18 20 46 80
2022/2023730 97 111 65 121 41 87 29 58 70 10 27 14
2023/2024270 18 74 7 7 10 33 20 9 7 10 29 46
2024/2025576 19 23 51 31 32 34 12 19 84 45 129 97
2025/20261.585 236 41 88 163 327 58 281 80 110 88 66 47
2026/202736 36 0 0 0 0 0 0 0 0 0 0 0
Totale 4.266